Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Testing efficacy or toxicity of a compound or composition
Reexamination Certificate
2006-09-05
2009-10-27
Swartz, Rodney P. (Department: 1645)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Testing efficacy or toxicity of a compound or composition
C424S009100, C424S130100, C424S184100, C424S234100, C424S248100, C424S283100, C435S004000, C435S007100
Reexamination Certificate
active
07608246
ABSTRACT:
The present invention is directed to pharmaceutical compositions that contain a combination of apolipoprotein E and an antigenic lipid. The compositions may be administered to a subject for the purpose of inducing an immune response against the lipid and in immunization protocols.
REFERENCES:
patent: 4816446 (1989-03-01), Feller et al.
patent: 5010063 (1991-04-01), Piani et al.
patent: 5039529 (1991-08-01), Bergendal et al.
patent: 5679347 (1997-10-01), Porcelli et al.
patent: 5853737 (1998-12-01), Modlin et al.
patent: 6238676 (2001-05-01), Porcelli et al.
patent: 6326476 (2001-12-01), Mattsson et al.
patent: 6953625 (2005-10-01), Koullick et al.
patent: 6969705 (2005-11-01), Pecquet et al.
patent: 7063844 (2006-06-01), Porcelli et al.
GenBank Submission; NIH/NCBI; Accession No. AF261279 and AF261279.1 (PRI Oct. 27, 2000).
GenBank Submission; NIH/NCBI; Accession No. AAA56833 and AAA56833.1 (PRI Nov. 30, 1994).
Barak et al., Fluorescent low density lipoprotein for observation of dynamics of individual receptor complexes on cultured human fibroblasts. J Cell Bio. Sep. 1981;90(3):595-604.
Basu et al., CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity. Mar. 2001;14(3):303-13.
Beatty et al., Trafficking and release of mycobacterial lipids from infected macrophages. Traffic. Mar. 2000;1(3):235-47.
Beisiegel et al., The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature. Sep. 14, 1989;341(6238):162-4. Abstract Only.
Boullier et al., Scavenger receptors, oxidized LDL, and atherosclerosis. Ann N Y Acad Sci. Dec. 2001;947:214-22; discussion 222-3. Abstract Only.
Brigl et al., CD1: antigen presentation and T cell function. Annu Rev Immunol. 2004;22:817-90. Abstract Only.
Chaussabel et al., Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood. Jul. 15, 2003;102(2):672-81.
Fazekas et al., Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurology. Sep. 11, 2001;57(5):853-7. Abstract Only.
Heeren et al., Intracellular metabolism of triglyceride-rich lipoproteins. Curr Opin Lipidol. Jun. 2001;12(3):255-60. Abstract Only.
Heeren et al., Recycling of apoprotein E is associated with cholesterol efflux and high density lipoprotein internalizaiton. J Biol Chem. Apr. 18, 2003;278(16):14370-8.
Kang et al., Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells. Nat Immunol. Feb. 2004;5(2): 175-81. Abstract Only.
Krul et al., Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins. J Clin Invest. Feb. 1985;75(2):361-9.
Le Naour et al., Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics. J Biol Chem. May 25, 2001;276(21):17920-31.
Mahley et al., Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet. 2000;1:507-37. Abstract Only.
Mahley et al., Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. Apr. 29, 1988;240(4852):622-30. Abstract Only.
Major et al., Quantitative and qualitative differences in proatherogenic NKT cells in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. Dec. 2004;24(12):2351-7.
Matsunaga et al., Mycobacterium tuberculosis pks12 produces a novel polyketide presented by CD1c to T cells. J Exp Med. Dec. 20, 2004;200(12):1559-69.
Nickerson et al., Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene. Genome Res. Oct. 2000;10(10):1532-45.
Paik et al., Nucleotide sequence and structure of the human apolipoprotein E gene. Proc. Natl Acad Sci U S A. May 1985;82(10):3445-9.
Prigozy et al., Glycolipid antigen processing for presentation by CD1d molecules. Science. Jan. 26, 2001;291(5504):664-7. Abstract Only.
Prigozy et al., the mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity. Feb. 1997;6(2):187-97. Abstract Only.
Rebbaa et al., Distribution of exogenously added gangliosides in serum proteins depends on the relative affinity of albumin and lipoproteins. J Lipid Res. Mar. 1995;36(3):564-72.
Sacks et al., The influence of apolipoprotein E on the interaction between normal human very low density lipoproteins and U937 human macrophages: heterogeneity among persons. Vasc Med. 1996;1(1):9-18. Abstract Only.
Shamshiev et al., Self glycolipids as T-cell autoantigens. Eur J Immunol. May 1999;29(5):1667-75. Abstract Only.
Südhof et al., The LDL receptor gene: a mosaic of exons shared with different proteins. Science. May 17, 1985;228(4701):815-22. Abstract Only.
Sugita et al., New insights into pathways for CD1-mediated antigen presentation. Curr Opin Immunol. Feb. 2004;16(1):90-5. Abstract Only.
Tupin et al., CDId-dependent activation of NKT cells aggravates atherosclerosis.J Exp Med. Feb. 2, 2004;199(3):417-22.
Van Den Elzen et al., Apolipoprotein-mediated pathways of lipid antigen presentation. Nature. Oct. 6, 2005;437(7060):906-10.
Van Den Elzen et al., Capture and specific delivery of exogenous lipid antigens by apolipoprotein E. Federation of Clinical Immunology Societies 2005 Meeting. Boston. May 11-16, 2005. Poster Abstract.
Van Den Elzen et al., Capture and specific delivery of exogenous lipid antigens by apolipoprotein E. Academy of Clinical Laboratory Physicians and Scientists. Pittsburgh. Jun. 9-11, 2005. Poster Abstract.
Winau et al., Saposin C is required for lipid presentation by human CD1b. Nat Immunol. Feb. 2004;5(2):169-74. Abstract Only.
Yamamoto et al., The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell. Nov. 1984;39(1):27-38. Abstract Only.
Zhou et al., Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science. Jan. 23, 2004;303(5657):523-7, Abstract Only.
Brenner Michael B.
van den Elzen Peter
Swartz Rodney P.
The Brigham and Women's Hospital, Inc.
Wolf Greenfield & Sacks P.C.
LandOfFree
Apolipoprotein E as an adjuvant for lipid antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apolipoprotein E as an adjuvant for lipid antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apolipoprotein E as an adjuvant for lipid antigens will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4056262